Dec 29, 2025 • MarketBeat
NEUTRAL
Harbor Capital Advisors Inc. Decreases Stake in U.S. Physical Therapy, Inc. $USPH
Harbor Capital Advisors Inc. significantly reduced its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 71% in the third quarter, retaining 6,401 shares valued at approximately $544,000. Despite this reduction in institutional ownership, U.S. Physical Therapy maintains a market capitalization of $1.23 billion, a P/E ratio of 34.03, and pays a quarterly dividend of $0.45. Analyst sentiment for USPH is mixed but leans positive, with an average "Moderate Buy" rating and a consensus price target of $105.33.
Dec 28, 2025 • MarketBeat
SOMEWHAT-BULLISH
U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Rating of "Moderate Buy" by Analysts
U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $105.33. The company's shares opened at $80.99, have a market cap of $1.23 billion, and offer a quarterly dividend of $0.45. Recent analyst actions include rating changes and price target adjustments from firms like Wall Street Zen, Weiss Ratings, Barrington Research, Citigroup, and JPMorgan Chase & Co.
Dec 26, 2025 • Sahm
SOMEWHAT-BULLISH
Should RBC’s Health Care Overweight Call and Sentiment Shift Require Action From U.S. Physical Therapy (USPH) Investors?
RBC Capital recently upgraded the S&P 500 Health Care sector to "Overweight," positively impacting sentiment for companies like U.S. Physical Therapy (USPH) due to attractive valuations and improving earnings trends. While this shift is favorable, investors in USPH should still focus on the company's core investment narrative, which relies on rising patient volumes, cost efficiencies, and clinic acquisitions to offset persistent reimbursement and labor challenges. Despite the positive sector outlook, individual investors may hold differing fair value estimates for USPH, necessitating a balanced perspective before making investment decisions.
Dec 25, 2025 • MarketBeat
NEUTRAL
U.S. Physical Therapy (NYSE:USPH) Stock Price Passes Above 200 Day Moving Average - Here's Why
U.S. Physical Therapy (NYSE:USPH) stock recently surpassed its 200-day moving average of $80.24, trading as high as $81.44 with a volume of 51,239 shares. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $105.33, despite a recent target reduction by JPMorgan. USPH pays a quarterly dividend of $0.45, equating to an annualized yield of approximately 2.2% and a payout ratio of 75.63%.
Dec 23, 2025 • Stock Traders Daily
SOMEWHAT-BULLISH
Why (USPH) Price Action Is Critical for Tactical Trading
This article analyzes U.s. Physical Therapy Inc. (NASDAQ: USPH) for tactical trading, highlighting a mid-channel oscillation pattern and conflicting sentiment across different time horizons. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for various risk profiles, along with key support and resistance levels. The analysis emphasizes an exceptional risk-reward setup targeting a 12.6% gain against 0.3% risk.
Dec 23, 2025 • Finviz
SOMEWHAT-BULLISH
U.S. Physical Therapy (USPH) Stock Trades Up, Here Is Why
Shares of U.S. Physical Therapy (USPH) jumped 3.7% after RBC Capital upgraded the S&P 500 Health Care sector to Overweight, citing attractive valuations and improving earnings trends. This broad positive sentiment for the sector contributed to the rise in USPH's shares, though they later cooled down to $80.46, up 3.3% from the previous close. The analyst upgrade outweighed previous concerns about the company's declining year-over-year profitability in a recent quarter, despite revenue growth.